Licogliflozin is a dual SGLT1 and SGLT2 Inhibitor
In general, obesity more greatly contributes to the global burden of disease (also associated with co-morbidities) in recent years . For instance, there are type 2 diabetes mellitus (T2DM), hypertension,…